chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Brain natriuretic peptide increased, C-reactive protein normal, COVID-19, COVID-19 pneumonia, Carbon dioxide increased
Clinical narrative: 49 Y male with history of HTN, HLD, DM2, ESRD (recent transition from PD to HD, T/Th/Sat), paroxysmal Afib (on warfarin), gout, ACD, recent admission 12/16 - 12/20 for hypervolemia (new start HD at that time) who presented 1/11/22 from home (ALF) with weakness SOB, chills, no fevers. He was found to have acute hypoxemic respiratory failure, Covid positive 1/11/22, abnormal troponin. Normal lactate.  CT chest with large left pleural effusion with atelectasis. Not short of breath at rest.  Started on antibiotics for possible parapneumonic effusion and Decadron for covid pna. No Remdesivir given ESRD. Thoracentesis 1/14/22, removal of 1.3 L of fluid.  Cultures so far negative.  Clinically improved, weaned to room air. Ambulatory on RA with O2 sats greater than 92%. Eating well.  CRP 1.6  from 8.9 on admission. D-dimer 2.71 from 3.30.    1) COVID Pneumonia, Acute hypoxemic Respiratory failure (resolved), PNA, L effusion- Symptom onset on 1/10. COVID positive on 1/11. Last fever unknown.  Vanco 1/11-15.  Zosyn in house 1/11-1/16. BCX neg.              - Vantin to complete 7 days total 1/17/22.               - consider CXR in 2 weeks to f/u L effusion             - Decadron 6mg PO qday for up to 10 days (1/11-1/19 ) given high risks for complications.              - Remdesivir not given as pt is ESRD              - Protonix for GI prophylaxis             - s/p Thoracentesis 1/14/22. GS no organisms. F/u pleural fluid cytology, and culture so far negative.              - continue isolation per Regional/Local ID guidance. Until 01/31/22.     2)  Non ischemic myocardial injury from Covid infection, pna. Trop  0.12 x 2.    3) HTN, HLD - PTA Metoprolol. Amlodipine increased to 5mg bid.  Added Hydralazine 25mg TID for HTN. Continue to adjust medication as outpt as appropriate.     4) AFib:  - on Warfarin. F/u with AC clinic, next INR on Tuesday on HD 1/18/22                 - PTA BB     5) DM: Last hgba1c 7.2. Pt states no longer takes NPH or regular insulin as his AM sugars are usually < 100. BG on admission was 71             - Here on low dose NPH and regular insulin (as he is on steroids) to tirate as outpt once off steroids.              - Low ISS   6) ESRD on HD             - Continue T,Th,Sat HD sessions at Covid center. After finish isolation he can go back to HD  MWF.              - Continue nephrovite              - Pt also taking Phoslo and Renvela .   -  ANEMIA: Suspect AOCD. Baseline hgb 8-9. No e/o bleeding             - iron tabs    - Gout:     - Continue PTA allopurinol   - Undiagnosed OSA: pt desaturates occasionally when sleeping requiring on and off oxygen. He has been told he needs sleep study and CPAP.              - e consult to home sleep study for CPAP sent.    -  Followed by derm for rash. Acne vs. Kyrle's disease.             - PTA Doxycycline 100mg Q12h resume.              - PTA Atarax 10mg daily PRN itching   Diet: DIET, RENAL DVT prophylaxis: As above Code Status: Full Code Reason for Hospital Admission (Admitting Diagnosis):  Covid infection
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Computerised tomogram thorax abnormal, Culture negative, Cytology normal, Dyspnoea
Clinical narrative: 49 Y male with history of HTN, HLD, DM2, ESRD (recent transition from PD to HD, T/Th/Sat), paroxysmal Afib (on warfarin), gout, ACD, recent admission 12/16 - 12/20 for hypervolemia (new start HD at that time) who presented 1/11/22 from home (ALF) with weakness SOB, chills, no fevers. He was found to have acute hypoxemic respiratory failure, Covid positive 1/11/22, abnormal troponin. Normal lactate.  CT chest with large left pleural effusion with atelectasis. Not short of breath at rest.  Started on antibiotics for possible parapneumonic effusion and Decadron for covid pna. No Remdesivir given ESRD. Thoracentesis 1/14/22, removal of 1.3 L of fluid.  Cultures so far negative.  Clinically improved, weaned to room air. Ambulatory on RA with O2 sats greater than 92%. Eating well.  CRP 1.6  from 8.9 on admission. D-dimer 2.71 from 3.30.    1) COVID Pneumonia, Acute hypoxemic Respiratory failure (resolved), PNA, L effusion- Symptom onset on 1/10. COVID positive on 1/11. Last fever unknown.  Vanco 1/11-15.  Zosyn in house 1/11-1/16. BCX neg.              - Vantin to complete 7 days total 1/17/22.               - consider CXR in 2 weeks to f/u L effusion             - Decadron 6mg PO qday for up to 10 days (1/11-1/19 ) given high risks for complications.              - Remdesivir not given as pt is ESRD              - Protonix for GI prophylaxis             - s/p Thoracentesis 1/14/22. GS no organisms. F/u pleural fluid cytology, and culture so far negative.              - continue isolation per Regional/Local ID guidance. Until 01/31/22.     2)  Non ischemic myocardial injury from Covid infection, pna. Trop  0.12 x 2.    3) HTN, HLD - PTA Metoprolol. Amlodipine increased to 5mg bid.  Added Hydralazine 25mg TID for HTN. Continue to adjust medication as outpt as appropriate.     4) AFib:  - on Warfarin. F/u with AC clinic, next INR on Tuesday on HD 1/18/22                 - PTA BB     5) DM: Last hgba1c 7.2. Pt states no longer takes NPH or regular insulin as his AM sugars are usually < 100. BG on admission was 71             - Here on low dose NPH and regular insulin (as he is on steroids) to tirate as outpt once off steroids.              - Low ISS   6) ESRD on HD             - Continue T,Th,Sat HD sessions at Covid center. After finish isolation he can go back to HD  MWF.              - Continue nephrovite              - Pt also taking Phoslo and Renvela .   -  ANEMIA: Suspect AOCD. Baseline hgb 8-9. No e/o bleeding             - iron tabs    - Gout:     - Continue PTA allopurinol   - Undiagnosed OSA: pt desaturates occasionally when sleeping requiring on and off oxygen. He has been told he needs sleep study and CPAP.              - e consult to home sleep study for CPAP sent.    -  Followed by derm for rash. Acne vs. Kyrle's disease.             - PTA Doxycycline 100mg Q12h resume.              - PTA Atarax 10mg daily PRN itching   Diet: DIET, RENAL DVT prophylaxis: As above Code Status: Full Code Reason for Hospital Admission (Admitting Diagnosis):  Covid infection
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Gout, Haematocrit decreased, Haemodialysis, Haemoglobin decreased, Hyperlipidaemia
Clinical narrative: 49 Y male with history of HTN, HLD, DM2, ESRD (recent transition from PD to HD, T/Th/Sat), paroxysmal Afib (on warfarin), gout, ACD, recent admission 12/16 - 12/20 for hypervolemia (new start HD at that time) who presented 1/11/22 from home (ALF) with weakness SOB, chills, no fevers. He was found to have acute hypoxemic respiratory failure, Covid positive 1/11/22, abnormal troponin. Normal lactate.  CT chest with large left pleural effusion with atelectasis. Not short of breath at rest.  Started on antibiotics for possible parapneumonic effusion and Decadron for covid pna. No Remdesivir given ESRD. Thoracentesis 1/14/22, removal of 1.3 L of fluid.  Cultures so far negative.  Clinically improved, weaned to room air. Ambulatory on RA with O2 sats greater than 92%. Eating well.  CRP 1.6  from 8.9 on admission. D-dimer 2.71 from 3.30.    1) COVID Pneumonia, Acute hypoxemic Respiratory failure (resolved), PNA, L effusion- Symptom onset on 1/10. COVID positive on 1/11. Last fever unknown.  Vanco 1/11-15.  Zosyn in house 1/11-1/16. BCX neg.              - Vantin to complete 7 days total 1/17/22.               - consider CXR in 2 weeks to f/u L effusion             - Decadron 6mg PO qday for up to 10 days (1/11-1/19 ) given high risks for complications.              - Remdesivir not given as pt is ESRD              - Protonix for GI prophylaxis             - s/p Thoracentesis 1/14/22. GS no organisms. F/u pleural fluid cytology, and culture so far negative.              - continue isolation per Regional/Local ID guidance. Until 01/31/22.     2)  Non ischemic myocardial injury from Covid infection, pna. Trop  0.12 x 2.    3) HTN, HLD - PTA Metoprolol. Amlodipine increased to 5mg bid.  Added Hydralazine 25mg TID for HTN. Continue to adjust medication as outpt as appropriate.     4) AFib:  - on Warfarin. F/u with AC clinic, next INR on Tuesday on HD 1/18/22                 - PTA BB     5) DM: Last hgba1c 7.2. Pt states no longer takes NPH or regular insulin as his AM sugars are usually < 100. BG on admission was 71             - Here on low dose NPH and regular insulin (as he is on steroids) to tirate as outpt once off steroids.              - Low ISS   6) ESRD on HD             - Continue T,Th,Sat HD sessions at Covid center. After finish isolation he can go back to HD  MWF.              - Continue nephrovite              - Pt also taking Phoslo and Renvela .   -  ANEMIA: Suspect AOCD. Baseline hgb 8-9. No e/o bleeding             - iron tabs    - Gout:     - Continue PTA allopurinol   - Undiagnosed OSA: pt desaturates occasionally when sleeping requiring on and off oxygen. He has been told he needs sleep study and CPAP.              - e consult to home sleep study for CPAP sent.    -  Followed by derm for rash. Acne vs. Kyrle's disease.             - PTA Doxycycline 100mg Q12h resume.              - PTA Atarax 10mg daily PRN itching   Diet: DIET, RENAL DVT prophylaxis: As above Code Status: Full Code Reason for Hospital Admission (Admitting Diagnosis):  Covid infection
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Hypertension, Hypervolaemia, Insulin therapy, International normalised ratio increased, Lipase normal
Clinical narrative: 49 Y male with history of HTN, HLD, DM2, ESRD (recent transition from PD to HD, T/Th/Sat), paroxysmal Afib (on warfarin), gout, ACD, recent admission 12/16 - 12/20 for hypervolemia (new start HD at that time) who presented 1/11/22 from home (ALF) with weakness SOB, chills, no fevers. He was found to have acute hypoxemic respiratory failure, Covid positive 1/11/22, abnormal troponin. Normal lactate.  CT chest with large left pleural effusion with atelectasis. Not short of breath at rest.  Started on antibiotics for possible parapneumonic effusion and Decadron for covid pna. No Remdesivir given ESRD. Thoracentesis 1/14/22, removal of 1.3 L of fluid.  Cultures so far negative.  Clinically improved, weaned to room air. Ambulatory on RA with O2 sats greater than 92%. Eating well.  CRP 1.6  from 8.9 on admission. D-dimer 2.71 from 3.30.    1) COVID Pneumonia, Acute hypoxemic Respiratory failure (resolved), PNA, L effusion- Symptom onset on 1/10. COVID positive on 1/11. Last fever unknown.  Vanco 1/11-15.  Zosyn in house 1/11-1/16. BCX neg.              - Vantin to complete 7 days total 1/17/22.               - consider CXR in 2 weeks to f/u L effusion             - Decadron 6mg PO qday for up to 10 days (1/11-1/19 ) given high risks for complications.              - Remdesivir not given as pt is ESRD              - Protonix for GI prophylaxis             - s/p Thoracentesis 1/14/22. GS no organisms. F/u pleural fluid cytology, and culture so far negative.              - continue isolation per Regional/Local ID guidance. Until 01/31/22.     2)  Non ischemic myocardial injury from Covid infection, pna. Trop  0.12 x 2.    3) HTN, HLD - PTA Metoprolol. Amlodipine increased to 5mg bid.  Added Hydralazine 25mg TID for HTN. Continue to adjust medication as outpt as appropriate.     4) AFib:  - on Warfarin. F/u with AC clinic, next INR on Tuesday on HD 1/18/22                 - PTA BB     5) DM: Last hgba1c 7.2. Pt states no longer takes NPH or regular insulin as his AM sugars are usually < 100. BG on admission was 71             - Here on low dose NPH and regular insulin (as he is on steroids) to tirate as outpt once off steroids.              - Low ISS   6) ESRD on HD             - Continue T,Th,Sat HD sessions at Covid center. After finish isolation he can go back to HD  MWF.              - Continue nephrovite              - Pt also taking Phoslo and Renvela .   -  ANEMIA: Suspect AOCD. Baseline hgb 8-9. No e/o bleeding             - iron tabs    - Gout:     - Continue PTA allopurinol   - Undiagnosed OSA: pt desaturates occasionally when sleeping requiring on and off oxygen. He has been told he needs sleep study and CPAP.              - e consult to home sleep study for CPAP sent.    -  Followed by derm for rash. Acne vs. Kyrle's disease.             - PTA Doxycycline 100mg Q12h resume.              - PTA Atarax 10mg daily PRN itching   Diet: DIET, RENAL DVT prophylaxis: As above Code Status: Full Code Reason for Hospital Admission (Admitting Diagnosis):  Covid infection
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: PCO2 increased, PO2 increased, Platelet count normal, Pleural effusion, Prothrombin time prolonged
Clinical narrative: 49 Y male with history of HTN, HLD, DM2, ESRD (recent transition from PD to HD, T/Th/Sat), paroxysmal Afib (on warfarin), gout, ACD, recent admission 12/16 - 12/20 for hypervolemia (new start HD at that time) who presented 1/11/22 from home (ALF) with weakness SOB, chills, no fevers. He was found to have acute hypoxemic respiratory failure, Covid positive 1/11/22, abnormal troponin. Normal lactate.  CT chest with large left pleural effusion with atelectasis. Not short of breath at rest.  Started on antibiotics for possible parapneumonic effusion and Decadron for covid pna. No Remdesivir given ESRD. Thoracentesis 1/14/22, removal of 1.3 L of fluid.  Cultures so far negative.  Clinically improved, weaned to room air. Ambulatory on RA with O2 sats greater than 92%. Eating well.  CRP 1.6  from 8.9 on admission. D-dimer 2.71 from 3.30.    1) COVID Pneumonia, Acute hypoxemic Respiratory failure (resolved), PNA, L effusion- Symptom onset on 1/10. COVID positive on 1/11. Last fever unknown.  Vanco 1/11-15.  Zosyn in house 1/11-1/16. BCX neg.              - Vantin to complete 7 days total 1/17/22.               - consider CXR in 2 weeks to f/u L effusion             - Decadron 6mg PO qday for up to 10 days (1/11-1/19 ) given high risks for complications.              - Remdesivir not given as pt is ESRD              - Protonix for GI prophylaxis             - s/p Thoracentesis 1/14/22. GS no organisms. F/u pleural fluid cytology, and culture so far negative.              - continue isolation per Regional/Local ID guidance. Until 01/31/22.     2)  Non ischemic myocardial injury from Covid infection, pna. Trop  0.12 x 2.    3) HTN, HLD - PTA Metoprolol. Amlodipine increased to 5mg bid.  Added Hydralazine 25mg TID for HTN. Continue to adjust medication as outpt as appropriate.     4) AFib:  - on Warfarin. F/u with AC clinic, next INR on Tuesday on HD 1/18/22                 - PTA BB     5) DM: Last hgba1c 7.2. Pt states no longer takes NPH or regular insulin as his AM sugars are usually < 100. BG on admission was 71             - Here on low dose NPH and regular insulin (as he is on steroids) to tirate as outpt once off steroids.              - Low ISS   6) ESRD on HD             - Continue T,Th,Sat HD sessions at Covid center. After finish isolation he can go back to HD  MWF.              - Continue nephrovite              - Pt also taking Phoslo and Renvela .   -  ANEMIA: Suspect AOCD. Baseline hgb 8-9. No e/o bleeding             - iron tabs    - Gout:     - Continue PTA allopurinol   - Undiagnosed OSA: pt desaturates occasionally when sleeping requiring on and off oxygen. He has been told he needs sleep study and CPAP.              - e consult to home sleep study for CPAP sent.    -  Followed by derm for rash. Acne vs. Kyrle's disease.             - PTA Doxycycline 100mg Q12h resume.              - PTA Atarax 10mg daily PRN itching   Diet: DIET, RENAL DVT prophylaxis: As above Code Status: Full Code Reason for Hospital Admission (Admitting Diagnosis):  Covid infection
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Rash, SARS-CoV-2 test positive, Sleep apnoea syndrome, Troponin abnormal, Troponin increased
Clinical narrative: 49 Y male with history of HTN, HLD, DM2, ESRD (recent transition from PD to HD, T/Th/Sat), paroxysmal Afib (on warfarin), gout, ACD, recent admission 12/16 - 12/20 for hypervolemia (new start HD at that time) who presented 1/11/22 from home (ALF) with weakness SOB, chills, no fevers. He was found to have acute hypoxemic respiratory failure, Covid positive 1/11/22, abnormal troponin. Normal lactate.  CT chest with large left pleural effusion with atelectasis. Not short of breath at rest.  Started on antibiotics for possible parapneumonic effusion and Decadron for covid pna. No Remdesivir given ESRD. Thoracentesis 1/14/22, removal of 1.3 L of fluid.  Cultures so far negative.  Clinically improved, weaned to room air. Ambulatory on RA with O2 sats greater than 92%. Eating well.  CRP 1.6  from 8.9 on admission. D-dimer 2.71 from 3.30.    1) COVID Pneumonia, Acute hypoxemic Respiratory failure (resolved), PNA, L effusion- Symptom onset on 1/10. COVID positive on 1/11. Last fever unknown.  Vanco 1/11-15.  Zosyn in house 1/11-1/16. BCX neg.              - Vantin to complete 7 days total 1/17/22.               - consider CXR in 2 weeks to f/u L effusion             - Decadron 6mg PO qday for up to 10 days (1/11-1/19 ) given high risks for complications.              - Remdesivir not given as pt is ESRD              - Protonix for GI prophylaxis             - s/p Thoracentesis 1/14/22. GS no organisms. F/u pleural fluid cytology, and culture so far negative.              - continue isolation per Regional/Local ID guidance. Until 01/31/22.     2)  Non ischemic myocardial injury from Covid infection, pna. Trop  0.12 x 2.    3) HTN, HLD - PTA Metoprolol. Amlodipine increased to 5mg bid.  Added Hydralazine 25mg TID for HTN. Continue to adjust medication as outpt as appropriate.     4) AFib:  - on Warfarin. F/u with AC clinic, next INR on Tuesday on HD 1/18/22                 - PTA BB     5) DM: Last hgba1c 7.2. Pt states no longer takes NPH or regular insulin as his AM sugars are usually < 100. BG on admission was 71             - Here on low dose NPH and regular insulin (as he is on steroids) to tirate as outpt once off steroids.              - Low ISS   6) ESRD on HD             - Continue T,Th,Sat HD sessions at Covid center. After finish isolation he can go back to HD  MWF.              - Continue nephrovite              - Pt also taking Phoslo and Renvela .   -  ANEMIA: Suspect AOCD. Baseline hgb 8-9. No e/o bleeding             - iron tabs    - Gout:     - Continue PTA allopurinol   - Undiagnosed OSA: pt desaturates occasionally when sleeping requiring on and off oxygen. He has been told he needs sleep study and CPAP.              - e consult to home sleep study for CPAP sent.    -  Followed by derm for rash. Acne vs. Kyrle's disease.             - PTA Doxycycline 100mg Q12h resume.              - PTA Atarax 10mg daily PRN itching   Diet: DIET, RENAL DVT prophylaxis: As above Code Status: Full Code Reason for Hospital Admission (Admitting Diagnosis):  Covid infection
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: White blood cell count normal
Clinical narrative: 49 Y male with history of HTN, HLD, DM2, ESRD (recent transition from PD to HD, T/Th/Sat), paroxysmal Afib (on warfarin), gout, ACD, recent admission 12/16 - 12/20 for hypervolemia (new start HD at that time) who presented 1/11/22 from home (ALF) with weakness SOB, chills, no fevers. He was found to have acute hypoxemic respiratory failure, Covid positive 1/11/22, abnormal troponin. Normal lactate.  CT chest with large left pleural effusion with atelectasis. Not short of breath at rest.  Started on antibiotics for possible parapneumonic effusion and Decadron for covid pna. No Remdesivir given ESRD. Thoracentesis 1/14/22, removal of 1.3 L of fluid.  Cultures so far negative.  Clinically improved, weaned to room air. Ambulatory on RA with O2 sats greater than 92%. Eating well.  CRP 1.6  from 8.9 on admission. D-dimer 2.71 from 3.30.    1) COVID Pneumonia, Acute hypoxemic Respiratory failure (resolved), PNA, L effusion- Symptom onset on 1/10. COVID positive on 1/11. Last fever unknown.  Vanco 1/11-15.  Zosyn in house 1/11-1/16. BCX neg.              - Vantin to complete 7 days total 1/17/22.               - consider CXR in 2 weeks to f/u L effusion             - Decadron 6mg PO qday for up to 10 days (1/11-1/19 ) given high risks for complications.              - Remdesivir not given as pt is ESRD              - Protonix for GI prophylaxis             - s/p Thoracentesis 1/14/22. GS no organisms. F/u pleural fluid cytology, and culture so far negative.              - continue isolation per Regional/Local ID guidance. Until 01/31/22.     2)  Non ischemic myocardial injury from Covid infection, pna. Trop  0.12 x 2.    3) HTN, HLD - PTA Metoprolol. Amlodipine increased to 5mg bid.  Added Hydralazine 25mg TID for HTN. Continue to adjust medication as outpt as appropriate.     4) AFib:  - on Warfarin. F/u with AC clinic, next INR on Tuesday on HD 1/18/22                 - PTA BB     5) DM: Last hgba1c 7.2. Pt states no longer takes NPH or regular insulin as his AM sugars are usually < 100. BG on admission was 71             - Here on low dose NPH and regular insulin (as he is on steroids) to tirate as outpt once off steroids.              - Low ISS   6) ESRD on HD             - Continue T,Th,Sat HD sessions at Covid center. After finish isolation he can go back to HD  MWF.              - Continue nephrovite              - Pt also taking Phoslo and Renvela .   -  ANEMIA: Suspect AOCD. Baseline hgb 8-9. No e/o bleeding             - iron tabs    - Gout:     - Continue PTA allopurinol   - Undiagnosed OSA: pt desaturates occasionally when sleeping requiring on and off oxygen. He has been told he needs sleep study and CPAP.              - e consult to home sleep study for CPAP sent.    -  Followed by derm for rash. Acne vs. Kyrle's disease.             - PTA Doxycycline 100mg Q12h resume.              - PTA Atarax 10mg daily PRN itching   Diet: DIET, RENAL DVT prophylaxis: As above Code Status: Full Code Reason for Hospital Admission (Admitting Diagnosis):  Covid infection
Age: 88.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19
Clinical narrative: COVID
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Electrocardiogram, Tachycardia
Clinical narrative: TACHYCARDIA.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19
Clinical narrative: COVID
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: The patient was disclosed of an event related to receiving their Moderna COVID-19 vaccine 4 days beyond the recommended expiration date. Per Moderna, the vaccine will maintain the necessary effectiveness against COVID-19. There is no further follow up needed with the patient.
Age: 44.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: COVID
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus, Urticaria
Clinical narrative: a few weeks after receiving the 2nd vaccine, I would break out in itchy red hives which last about 2 hrs and then slowly subside. They would come daily, and show up in different parts of my body- mainly extremeties, trunk, and palmar hand and sole of feet. I would put benadryl cream on them if it was itching particularily badly. After about 3 months I thought I may have developed a gluten sensitivity and decided to eat a gluten free diet. The hives continues and slowly have subsided after 6-8 months.  I have not been ill, or have I tested positive for Covid at any time since the hives started.
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Atypical pneumonia, Blood creatinine increased, Blood glucose normal, Blood lactic acid, Blood potassium increased
Clinical narrative: Pt presented to ED for increased confusion and fly signs and symptoms.  Tested for COVID and was positive on 1/21/2022.  In the emergency room patient's heart rate was 115 her respirations 24.  O2 sat was 97% on 4 L.  Her WBCs were 13.17, hemoglobin 10, hematocrit 33, platelets 191.  Her sodium was once 33 and potassium 6.4.  Her blood sugar was 173, BUN 40 and creatinine 3.3.  Her troponin is 47 and proBNP is 156.  Lipase level is 91.  Lactic acid is 1.0.  She is COVID positive.  Chest x-ray shows emphysema superimposed bilateral patchy infiltrates.  Differential considerations include atypical multifocal pneumonia, atypical edema and/or neoplasm.  Patient was vaccinated with Moderna 4/7/21 & 5/5/21. Discharged from hospital 1/31/22.
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood sodium decreased, Blood urea increased, COVID-19, Chest X-ray abnormal, Confusional state
Clinical narrative: Pt presented to ED for increased confusion and fly signs and symptoms.  Tested for COVID and was positive on 1/21/2022.  In the emergency room patient's heart rate was 115 her respirations 24.  O2 sat was 97% on 4 L.  Her WBCs were 13.17, hemoglobin 10, hematocrit 33, platelets 191.  Her sodium was once 33 and potassium 6.4.  Her blood sugar was 173, BUN 40 and creatinine 3.3.  Her troponin is 47 and proBNP is 156.  Lipase level is 91.  Lactic acid is 1.0.  She is COVID positive.  Chest x-ray shows emphysema superimposed bilateral patchy infiltrates.  Differential considerations include atypical multifocal pneumonia, atypical edema and/or neoplasm.  Patient was vaccinated with Moderna 4/7/21 & 5/5/21. Discharged from hospital 1/31/22.
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Emphysema, General symptom, Haematocrit decreased, Haemoglobin decreased, Lipase normal
Clinical narrative: Pt presented to ED for increased confusion and fly signs and symptoms.  Tested for COVID and was positive on 1/21/2022.  In the emergency room patient's heart rate was 115 her respirations 24.  O2 sat was 97% on 4 L.  Her WBCs were 13.17, hemoglobin 10, hematocrit 33, platelets 191.  Her sodium was once 33 and potassium 6.4.  Her blood sugar was 173, BUN 40 and creatinine 3.3.  Her troponin is 47 and proBNP is 156.  Lipase level is 91.  Lactic acid is 1.0.  She is COVID positive.  Chest x-ray shows emphysema superimposed bilateral patchy infiltrates.  Differential considerations include atypical multifocal pneumonia, atypical edema and/or neoplasm.  Patient was vaccinated with Moderna 4/7/21 & 5/5/21. Discharged from hospital 1/31/22.
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Lung infiltration, N-terminal prohormone brain natriuretic peptide increased, Neoplasm, Oedema, Platelet count normal
Clinical narrative: Pt presented to ED for increased confusion and fly signs and symptoms.  Tested for COVID and was positive on 1/21/2022.  In the emergency room patient's heart rate was 115 her respirations 24.  O2 sat was 97% on 4 L.  Her WBCs were 13.17, hemoglobin 10, hematocrit 33, platelets 191.  Her sodium was once 33 and potassium 6.4.  Her blood sugar was 173, BUN 40 and creatinine 3.3.  Her troponin is 47 and proBNP is 156.  Lipase level is 91.  Lactic acid is 1.0.  She is COVID positive.  Chest x-ray shows emphysema superimposed bilateral patchy infiltrates.  Differential considerations include atypical multifocal pneumonia, atypical edema and/or neoplasm.  Patient was vaccinated with Moderna 4/7/21 & 5/5/21. Discharged from hospital 1/31/22.
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test positive, Troponin increased, White blood cell count increased
Clinical narrative: Pt presented to ED for increased confusion and fly signs and symptoms.  Tested for COVID and was positive on 1/21/2022.  In the emergency room patient's heart rate was 115 her respirations 24.  O2 sat was 97% on 4 L.  Her WBCs were 13.17, hemoglobin 10, hematocrit 33, platelets 191.  Her sodium was once 33 and potassium 6.4.  Her blood sugar was 173, BUN 40 and creatinine 3.3.  Her troponin is 47 and proBNP is 156.  Lipase level is 91.  Lactic acid is 1.0.  She is COVID positive.  Chest x-ray shows emphysema superimposed bilateral patchy infiltrates.  Differential considerations include atypical multifocal pneumonia, atypical edema and/or neoplasm.  Patient was vaccinated with Moderna 4/7/21 & 5/5/21. Discharged from hospital 1/31/22.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Mammogram
Clinical narrative: Swollen lymph node under left armpit (noticed by PA during annual physical exam).
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: General symptom
Clinical narrative: symptom onset 1/12/22
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Bronchospasm, Chills, Headache, Heart rate increased
Clinical narrative: Fever of 101.7 started 12 hours after vaccination, with rapid heart rate, chills, headache. @4 hours later started wheezing. has been wheezing now with some bronchospasm x 3 days. Denies shortness of breath or chest pain. Her vital signs are stable wnl except BP is 130/90. treating with albuterol, oral steroids and benadryl.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test negative, Wheezing
Clinical narrative: Fever of 101.7 started 12 hours after vaccination, with rapid heart rate, chills, headache. @4 hours later started wheezing. has been wheezing now with some bronchospasm x 3 days. Denies shortness of breath or chest pain. Her vital signs are stable wnl except BP is 130/90. treating with albuterol, oral steroids and benadryl.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema annulare, Rash
Clinical narrative: Within 2 days of getting the vaccine, I had a rash appear on my hip. It was an Erythema annulare centrifugum (EAC) rash. The dermatologist I saw said to let it be and it should resolve on its own. He said it could very well have been related to the vaccine, but he couldn't say for certain.
Age: 94.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Unevaluable event
Clinical narrative: patient hospitalized
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: unknown
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Headache, Tinnitus, Vaccine positive rechallenge
Clinical narrative: Actually started after my initial two doses which were given on 12/22/2021 and 01/12/2021.  After these doses I started getting headaches and eventually ringing in my ears (tinnitus). These symptoms lasted for months and I had a doctors visit on July 6, 2021 about the headaches and I mentioned the tinnitus. In about October the headaches seemed to subside and the tinnitus had diminished. Then on November 2, 2021 I received the third shot (booster) and a few days later the headaches came back and the tinnitus came back as well. Today the headaches have subsided but the tinnitus is always present with some days it being more intense than others. The COVID19 (Pfizer-BioNTech) shots I received in December and January of 2021 have the following lot numbers (EK9231) and (EL3246).
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Headache, Loss of personal independence in daily activities, Mobility decreased, Syncope
Clinical narrative: 02/26/2021 vaccination. About 42 minutes later, I started to experience a HA. This HA became debilitating, lasting about 10 full days. The side affects from the HA lasted about 5 days thereafter. Hard to maintain normal daily activities, could hardly get out of bed. I did see a doctor after 10 days; prescribed HA medicine (I can't remember the name of the medicine). I started to experience syncope about the 6th day after vaccination, lasting about 20 days. Dr. kept stating to call the CDC as it was due to the vaccine.
Age: 89.0
Sex: F
Vaccine: VARZOS
Symptoms: Cellulitis, Erythema
Clinical narrative: Patient stated the next day she had severe redness in her arm that was vaccinated.  It continued to spread down so her provider so he gave her an antibiotic shot and then prescribed on 11/23/21 cephalexin 1000mg twice daily for 10 days.  Then a prednisone 40mg daily for 5 days on 11/30/21.  Then on 12/10/21 he did another dose of cephalexin 1000mg twice daily for 10 days.  She said her provider said she was lucky to keep her arm.  Prior to administration we always alcohol swab the area and wait for it to dry.   She said it was cellulitis.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Cough, Dyspnoea, Feeling abnormal, Nausea
Clinical narrative: MA administered Pfizer booster vaccine at 9:47am. MA came to this RN to notify that pt felt nauseous at 9:50am. Instructed MA to give pt graham crackers and cranberry juice. After 3 minutes, this RN went to check on pt. Pt stated she felt chest pain and pointed to her mid sternum. Pt stated it was a dull, throbbing pain and 8/10 on pain scale. Pt is an asthmatic and stated "she never felt like this before." This RN informed MA to call the medical emergency phone number and instructed MA to get AED in parking garage office and notify manager.    This RN asked if pt had difficulty breathing or throat swelling. Pt stated she felt fine. This RN determined to place the pt on 2L of O2 via venturi mask. Pt stated she could breathe better, but still felt nauseous. 3 minutes later, pt stated, "her throat was closing in." This RN administered epi x1 0.3mg IM at 10:10am. Removed pt from car and placed on ground. Pt stated she felt nauseous and started coughing. Turned pt to left side. Pt asked if she could sit up and use her inhaler in the car. RN manager arrived on scene. This RN gave pt's inhaler and she administered 2 puffs every 2 minutes that totaled 6 puffs. Pt remained on 2L of O2 . At 10:20am, pt stated she "felt better." Ambulance and public safety arrived to scene. Safety report submitted
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Throat tightness
Clinical narrative: MA administered Pfizer booster vaccine at 9:47am. MA came to this RN to notify that pt felt nauseous at 9:50am. Instructed MA to give pt graham crackers and cranberry juice. After 3 minutes, this RN went to check on pt. Pt stated she felt chest pain and pointed to her mid sternum. Pt stated it was a dull, throbbing pain and 8/10 on pain scale. Pt is an asthmatic and stated "she never felt like this before." This RN informed MA to call the medical emergency phone number and instructed MA to get AED in parking garage office and notify manager.    This RN asked if pt had difficulty breathing or throat swelling. Pt stated she felt fine. This RN determined to place the pt on 2L of O2 via venturi mask. Pt stated she could breathe better, but still felt nauseous. 3 minutes later, pt stated, "her throat was closing in." This RN administered epi x1 0.3mg IM at 10:10am. Removed pt from car and placed on ground. Pt stated she felt nauseous and started coughing. Turned pt to left side. Pt asked if she could sit up and use her inhaler in the car. RN manager arrived on scene. This RN gave pt's inhaler and she administered 2 puffs every 2 minutes that totaled 6 puffs. Pt remained on 2L of O2 . At 10:20am, pt stated she "felt better." Ambulance and public safety arrived to scene. Safety report submitted
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Unevaluable event
Clinical narrative: patient hospitalized
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: The patient was disclosed of an event related to receiving their Moderna COVID-19 vaccine 4 days beyond the recommended expiration date. Per Moderna, the vaccine will maintain the necessary effectiveness against COVID-19. There is no further follow up needed with the patient.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: Covid
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Patient was 17 years old at the time of receiving his first dose of Moderna. Attempted to call patient with phone number on record-no contact made.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Hypertension
Clinical narrative: I have had high blood pressure ever since getting the vaccine. It has been 160 over high 90s that lasted for 2 or 3 months. Now it is finally down to normal. I have always had low blood pressure. My doctor told me to watch my blood pressure, and if it stays high then he will have to treat it. He never got to treat it because it has came down now. It started coming down at the end of December 2021 and beginning of January 2022.
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Unevaluable event
Clinical narrative: patient hospitalized
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: Biopsy, Choking, Endoscopy abnormal, Eosinophilic oesophagitis, Oesophageal food impaction
Clinical narrative: On 6/19/22 patient was out to dinner and experienced a choking episode. Seen at local County Hospital and diagnosed with a food impaction. No PEDS GI available to transported by parents to alternate Hospital. Kept overnight. Impaction was removed and a biopsy was done by endoscopy on 6/20. Diagnosed with EOE. No history of EOE or food allergies previously. Had f/u visit and repeat endoscopy in September 2021. Absolutely no EOE seen on biopsy and no symptoms since original episode. No new foods or medicines prior to 6/19 episode. Seen by allergist and no allergies found.  Allergist concluded this may have been related to the Pfizer vaccine.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Computerised tomogram abnormal, Headache, Hypersensitivity, Lacrimation increased, Magnetic resonance imaging
Clinical narrative: I had a headache, running nose, sneezing, and water eyes for 3 days. Then a week later, my allergies started acting up. I went to see my doctor. He put me on antibodies and steroids'. Then I got a rash on my month. The rash never went away. The roof of my mouth is painful. The referred me to ENT. They did a CT scan and said that I have a tumor in side my nose. On Tuesday, he sent me to get a MRI done to make sure it was not cancer.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Neoplasm, Oral mucosal eruption, Oral pain, Rhinorrhoea, Sneezing
Clinical narrative: I had a headache, running nose, sneezing, and water eyes for 3 days. Then a week later, my allergies started acting up. I went to see my doctor. He put me on antibodies and steroids'. Then I got a rash on my month. The rash never went away. The roof of my mouth is painful. The referred me to ENT. They did a CT scan and said that I have a tumor in side my nose. On Tuesday, he sent me to get a MRI done to make sure it was not cancer.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: After administration it was discovered that vaccine dose administered was from a vial opened 5 days prior & not disposed of appropriately. It was left in a bag & un-refrigerated. There was no adverse event on the part of the patient.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: (+) Covid-19 infection 10/08/21. Cough, sore throat, headache, nasal congestion, loss of taste/smell, SOB, elevated heart rate, and fatigue. Out of work 6 wks.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Death, SARS-CoV-2 test positive
Clinical narrative: Patient contracted COVID-19 and passed away. NO booster.
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: Interchange of vaccine products, No adverse event
Clinical narrative: Patient received a COVID19 vaccine, however, the patient was expecting to receive a flu vaccine instead.  The error was identified by the nurse administering the vaccine.  Patient remained in the waiting area at the pharmacy for approximately 2 hours after the injection, with no visible signs or symptoms of an adverse reaction.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Patient was underage at the time of vaccination. Vaccine center attempted to reach patient with number on file but no contact was made.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: The patient was disclosed of an event related to receiving their Moderna COVID-19 vaccine 4 days beyond the recommended expiration date. Per Moderna, the vaccine will maintain the necessary effectiveness against COVID-19. There is no further follow up needed with the patient.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Fall, Syncope
Clinical narrative: Patient fainted 1 minute after receiving vaccine and fell to floor.
Age: 5.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, Product preparation issue
Clinical narrative: It was found that the pt likely received an undiluted peds dose of Pfizer vaccine.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: General symptom
Clinical narrative: symptom onset 1/13/22
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Patient presented to clinic with father for #1 COVID-19 vaccine. Vaccine administered today: Moderna. Dose given today: Dose #1. Patient monitored for 15 minutes. Since patient is under 18 years of age, he should have received Pfizer vaccine. Incident discovered after patient and parent left clinic. Incident report completed. Clinic manager notified. Called patient's father. Discussed error and to follow-up in 28 days for Pfizer vaccine. Per vaccination guidelines, "if age 5 to 17 years and Moderna was given in error, consider the age-appropriate Pfizer-BioNTech formulation as the second dose (based on the recipient's age on the day of vaccination) at least 28 days after the Moderna dose."
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Exposure to SARS-CoV-2, Malaise, Nasopharyngitis, SARS-CoV-2 test negative
Clinical narrative: On 01/10/2022 was feeling unwell and call in urgent care and was tested 01/11/2022 positive COVID, 10 days later 01/22/2022 negative COVID. Experience with COVID mild case cold symptom and tested positive instance clinic and 10 days negative at rite aid drive through clinic. Entire family exposure to COVID and all vaccinated and boosted so did not have a serious issue with COVID case.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: On 01/10/2022 was feeling unwell and call in urgent care and was tested 01/11/2022 positive COVID, 10 days later 01/22/2022 negative COVID. Experience with COVID mild case cold symptom and tested positive instance clinic and 10 days negative at rite aid drive through clinic. Entire family exposure to COVID and all vaccinated and boosted so did not have a serious issue with COVID case.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Illness, Influenza like illness, Mobility decreased, Oropharyngeal pain, Pain
Clinical narrative: I started having flu like symptoms: body aches, fever and sore throat. I just stayed home and stayed in bed. I was ill for about 3 weeks. I self treated with OTC medications.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: I started having flu like symptoms: body aches, fever and sore throat. I just stayed home and stayed in bed. I was ill for about 3 weeks. I self treated with OTC medications.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Atrioventricular block, Cardiac stress test, Dyspnoea, Echocardiogram, Electrocardiogram
Clinical narrative: Irregular heartbeat, fatigue, shortness of breath - ER - heartblock   May not have anything to do with vaccine...
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Electrocardiogram ambulatory, Fatigue, Heart rate irregular, Sleep study
Clinical narrative: Irregular heartbeat, fatigue, shortness of breath - ER - heartblock   May not have anything to do with vaccine...
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Patient was underage at the time of vaccination. Attempted to make contact with patient using number on file-no contact made.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Immediate post-injection reaction, Throat irritation, Urticaria
Clinical narrative: Immediately after receiving Pfizer booster to right arm patient started to have itching in her throat, some hives noted to left of neck. Patient was able to swallow water. She was given Benadryl 25 mg 1 tab orally. States is feeling fine approximately 5 minutes. She did wait her total of 15 minutes and went back to work.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: After administration of the vaccine it was determined that the dose was given from a vial opened 5 days prior & not disposed of appropriately.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: The patient was disclosed of an event related to receiving their Moderna COVID-19 vaccine 4 days beyond the recommended expiration date. Per Moderna, the vaccine will maintain the necessary effectiveness against COVID-19. There is no further follow up needed with the patient.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Brain natriuretic peptide increased, Cardiac failure congestive, Cardiomegaly, Chest X-ray abnormal, Dyspnoea
Clinical narrative: Started having shortness of breath which increased over time for two weeks eventually causing distress requiring hospital ER admit and inpatient admission. Increased work of breathing, diaphoretic, speaking in 1-2 words only. Elevated troponin and BNP found. On CXR, moderate cardiomegaly and CHF found.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Hyperhidrosis, Respiratory distress, Speech disorder, Troponin increased
Clinical narrative: Started having shortness of breath which increased over time for two weeks eventually causing distress requiring hospital ER admit and inpatient admission. Increased work of breathing, diaphoretic, speaking in 1-2 words only. Elevated troponin and BNP found. On CXR, moderate cardiomegaly and CHF found.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Cardiac stress test, Chest X-ray, Computerised tomogram thorax, Dizziness
Clinical narrative: Shortness of breath, dizziness, headaches, trouble sleeping
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Echocardiogram, Electrocardiogram, Gaze palsy, Insomnia
Clinical narrative: Shortness of breath, dizziness, headaches, trouble sleeping
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Pulmonary function test, SARS-CoV-2 test negative
Clinical narrative: Shortness of breath, dizziness, headaches, trouble sleeping
Age: 10.0
Sex: F
Vaccine: COVID19
Symptoms: Product preparation issue
Clinical narrative: It was found that the patient received a dose from a vial that was probably not diluted.
Age: 17.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Patient was underage at vaccination time for both doses of Moderna. Vaccination facility attempted to reach out to patient using phone number on file-no contact made.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: After administration of the vaccine it was determined that the dose was given from a vial opened 5 days prior & not disposed of appropriately.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Blood urine present, Chromaturia, Culture urine positive, Discomfort
Clinical narrative: Around January 15th, 2022, I began to have symptoms of what seemed like a bladder infection, but was far more serious. The urine was a brown color. When I woke up, I have strong pain on my low back, on my right side. My urine became dark brown and bloody. I went to urgent care on January 16th due to the pain, and it was identified as a right kidney infection. I was given strong antibiotics and pain medicine, I was also given a shot in my arm to just manage the pain, which caused me to faint for 30 seconds. The medications administered were ciprofloxacin, and hydrocodone acetamin, the shot I was given was ketolarac. Over the course of a few days, the infection got better. There is no longer bloody urine that is a brown color, just a slight lingering sore feeling.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Kidney infection
Clinical narrative: Around January 15th, 2022, I began to have symptoms of what seemed like a bladder infection, but was far more serious. The urine was a brown color. When I woke up, I have strong pain on my low back, on my right side. My urine became dark brown and bloody. I went to urgent care on January 16th due to the pain, and it was identified as a right kidney infection. I was given strong antibiotics and pain medicine, I was also given a shot in my arm to just manage the pain, which caused me to faint for 30 seconds. The medications administered were ciprofloxacin, and hydrocodone acetamin, the shot I was given was ketolarac. Over the course of a few days, the infection got better. There is no longer bloody urine that is a brown color, just a slight lingering sore feeling.